title: Angiotensin I-converting enzyme (CD143) is down-regulated in focal nodular hyperplasia of the liver.
abstract: In surgical pathology, focal nodular hyperplasia (FNH) is sometimes difficult to diagnose, and liver cirrhosis (LC) and hepatocellular adenoma (HA) are often among the differential diagnoses. Recently, we found a reduced expression of angiotensin I-converting enzyme (CD143) in FNH compared with cirrhotic and noncirrhotic liver. Intrigued by this observation, we investigated the expression pattern of CD143 in FNH, LC, and HA and its possible diagnostic value. The expression of CD143 was studied by immunohistochemistry in 20 FNHs, 13 corresponding extralesional noncirrhotic liver parenchyma, 20 patients with LC, and four HAs. Endothelial cells were identified with antibodies directed against CD31 and CD34. CD31+, CD34+, and CD143+ sinusoidal endothelial cells were found in extralesional liver, LC, HA, and FNH. However, the number of CD143+ sinusoidal endothelial cells and the intensity of immunostaining were significantly reduced in FNH compared with extralesional liver, LC, and HA. The expression of CD143 was further assessed using a numerical scoring system ranging from 0 to 6. The mean immunoreactivity score for CD143 was 2.4 +/- 1.7 for sinusoidal endothelial cells in FNH, 5.7 +/- 0.6 in extralesional liver, 4.8 +/- 1.1 in LC, and 5.8 +/- 0.5 in HA. The differences between the mean immunoreactivity scores for CD143 were highly significant. The difference between FNH and extralesional liver was confirmed on transcriptional level by fluorescence-mediated real-time RT-PCR, which also showed a significantly decreased level of CD143 mRNA in FNH. Our study provides evidence that CD143 is down-regulated in FNHs and that the phenotype of endothelial cells lining the sinusoids in FNH differs from those in non-neoplastic liver, LC, and HA. The observed variations in expression patterns for CD143 might be of diagnostic use in surgical pathology.
authors.affiliation: Department of Pathology and dagger Institute of Experimental Internal Medicine, Otto-von-Guericke-University, Magdeburg, Germany.
authors.forename: Ilona
authors.initials: I
authors.lastname: Gräntzdörffer
authors.forename: Uwe
authors.initials: U
authors.lastname: Lendeckel
authors.forename: Stacy
authors.initials: S
authors.lastname: Carl-McGrath
authors.forename: Albert
authors.initials: A
authors.lastname: Roessner
authors.forename: Christoph
authors.initials: C
authors.lastname: Röcken
mesh_terms: D018248:Adenoma, Liver Cell / Q000201:enzymology / Q000473:pathology; D000293:Adolescent; D000328:Adult; D002648:Child; D003937:Diagnosis, Differential; D015536:Down-Regulation; D005260:Female; D020518:Focal Nodular Hyperplasia / Q000201:enzymology* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D008099:Liver / Q000201:enzymology* / Q000473:pathology; D008103:Liver Cirrhosis / Q000201:enzymology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D007703:Peptidyl-Dipeptidase A / Q000096:biosynthesis*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D007703:Peptidyl-Dipeptidase A